Ensoma

Developer of in vivo hematopoietic stem cell engineering for genomic medicine

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups52 employees language ensoma.com

Registered entities

Social engagement

Social engagement: 11.1K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

20 investors on record; lead investors include 5AM Ventures, Arix Bioscience.

Investor typeCountShare
Venture capital840%
Private equity315%
Bank & private debt15%
Other / undisclosed840%

Recent activity

24 Jun 2026
Event
BIO2026
15 Jun 2026
Event
BIO International Convention on In Vivo Hematopoietic Stem Cell Engineering for One-Time Genetic Medicines
8 May 2026
Event
American Society of Gene & Cell Therapy annual meeting
Coming soon